Immatics Correlations

IMTX Stock

USD 7.18 0.09 1.24%

The current 90-days correlation between Immatics NV and Keros Therapeutics is 0.08 (i.e., Significant diversification). The correlation of Immatics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Immatics Correlation With Market

Average diversification

The correlation between Immatics NV and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immatics NV and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Immatics Stock

0.85	VALN	Valneva SE ADR	Pair Corr
0.83	ERNA	Eterna Therapeutics	Pair Corr
0.81	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.79	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.9	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.86	PFE	Pfizer Inc Buyout Trend	Pair Corr
0.62	INBX	Inhibrx Symbol Change	Pair Corr
0.78	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.85	MRVI	Maravai Lifesciences	Pair Corr
0.76	NUVL	Nuvalent	Pair Corr
0.93	REGN	Regeneron Pharmaceuticals	Pair Corr
0.65	ABBV	AbbVie Inc	Pair Corr
0.87	AKAN	Akanda Corp	Pair Corr
0.84	AMGN	Amgen Inc	Pair Corr
0.76	ANRO	Alto Neuroscience,	Pair Corr
0.63	APGE	Apogee Therapeutics,	Pair Corr
0.7	ARDX	Ardelyx	Pair Corr
0.73	SMMT	Summit Therapeutics PLC	Pair Corr

Moving against Immatics Stock

0.87	BMY	Bristol Myers Squibb	Pair Corr
0.78	GILD	Gilead Sciences	Pair Corr
0.73	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.61	DYAI	Dyadic International	Pair Corr
0.37	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.67	MNMD	Mind Medicine	Pair Corr
0.61	ABCL	Abcellera Biologics	Pair Corr
0.47	MOLN	Molecular Partners	Pair Corr
0.89	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	CRNX	ALXO	BCAB	AVTE	KROS	SNDX	MLYS	REPL	JANX	FENC
CRNX		-0.53	0.17	0.67	0.29	0.07	0.54	0.41	0.44	0.04	CRNX
ALXO	-0.53		-0.1	-0.65	-0.02	0.17	-0.39	-0.24	-0.16	0.27	ALXO
BCAB	0.17	-0.1		-0.19	0.52	0.78	0.72	-0.09	-0.24	-0.63	BCAB
AVTE	0.67	-0.65	-0.19		0.0	-0.33	0.21	0.57	0.45	0.27	AVTE
KROS	0.29	-0.02	0.52	0.0		0.57	0.42	0.02	-0.13	-0.31	KROS
SNDX	0.07	0.17	0.78	-0.33	0.57		0.56	-0.31	-0.33	-0.59	SNDX
MLYS	0.54	-0.39	0.72	0.21	0.42	0.56		0.18	0.07	-0.31	MLYS
REPL	0.41	-0.24	-0.09	0.57	0.02	-0.31	0.18		0.33	0.58	REPL
JANX	0.44	-0.16	-0.24	0.45	-0.13	-0.33	0.07	0.33		0.43	JANX
FENC	0.04	0.27	-0.63	0.27	-0.31	-0.59	-0.31	0.58	0.43		FENC
	CRNX	ALXO	BCAB	AVTE	KROS	SNDX	MLYS	REPL	JANX	FENC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SNDX	+ 0.78	BCAB
MLYS	+ 0.72	BCAB
AVTE	+ 0.67	CRNX
FENC	+ 0.58	REPL
REPL	+ 0.57	AVTE
SNDX	+ 0.57	KROS

High negative correlations

AVTE	- 0.65	ALXO
FENC	- 0.63	BCAB
FENC	- 0.59	SNDX
ALXO	- 0.53	CRNX
MLYS	- 0.39	ALXO
JANX	- 0.33	SNDX

Risk-Adjusted Indicators

There is a big difference between Immatics Stock performing well and Immatics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immatics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRNX	1.78	0.02	0.00	0.09	2.89	(1.58)	2.74	(3.82)	16.75
ALXO	4.17	(0.20)	0.00	(0.19)	0.00	0.00	10.67	(9.46)	26.52
BCAB	4.36	(0.34)	0.00	(0.11)	0.00	0.00	12.86	(7.59)	31.41
AVTE	2.39	0.45	0.18	0.62	1.99	(3.41)	5.58	(3.86)	19.11
KROS	3.67	(0.97)	0.00	(0.25)	0.00	0.00	6.18	(4.80)	82.94
SNDX	2.39	(0.53)	0.00	(0.11)	0.00	0.00	3.98	(5.34)	34.00
MLYS	2.85	0.04	0.03	0.08	3.48	(2.94)	7.51	(5.79)	20.98
REPL	3.10	0.26	0.06	0.42	3.36	(3.50)	8.25	(5.60)	46.30
JANX	3.24	0.43	0.13	1.15	2.86	(4.40)	6.87	(5.02)	54.12
FENC	3.30	0.22	0.07	0.18	3.67	(4.22)	7.87	(6.68)	23.48

Immatics Corporate Management

Andrea Mokler	VP Sciences	Profile
Miriam Meyer	VP Affairs	Profile
PHR MBA	Director HR	Profile
Edward Sturchio	General Secretary	Profile
Arnd MBA	Chief Officer	Profile
Toni Weinschenk	CoFounder Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC